首页 > 市场调查报告书 > 汽车工业

运输/物流

市场调查报告书

商品编码

1382549

全球医药物流市场 - 2023-2030

Global Pharmaceutical Logistics Market - 2023-2030

出版日期: 2023年11月17日 | 出版商:

DataM Intelligence | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

医药物流涉及製造、加工、运输材料和资源。它甚至涉及与向客户处理製成品相关的活动。对于任何一家製药公司来说，物流公司在其运作中发挥着非常关键的作用。原因是他们有责任按时交付设备和药品，因为有时会出现危急和紧急情况，患者迫切需要它们。在这种情况下，每一秒都很重要。

药品物流是任何製药企业营运中最重要的阶段之一，因为这些活动具有高度的时间敏感度。在正确的时间、地点和剂量为正确的患者提供正确的药物非常重要，最重要的是以正确的价格。

市场动态：驱动因素与限制因素

冷链物流进步不断

冷链物流的进步是预测期间推动市场发展的重要因素之一。冷链物流确保药品在特定温度范围内储存和运输，以保持其功效和安全性。温度监控和控制技术的进步有助于防止温度偏差，并降低产品变质的风险。

例如，2021 年 2 月，领先的供应链视觉性供应商 Sensitech 扩展了其物联网设备套件，纳入了航空公司批准的非锂电池型号，用于在货物通过飞机运输时即时追踪货物。

TempTale GEO 和 VizComm View 产品的增强系列支援包括疫苗、药品和测试套件在内的运输，并提供经过验证的资料，从而能够做出关键的接受/拒绝决策，无论货物如何移动- 空中、陆地或海上。 Sensitech 是 Carrier Global Corporation 的一部分，Carrier Global Corporation 是全球领先的健康、安全和永续建筑和冷链解决方案提供商。

此外，医药产业的成长、医药产业逆向物流需求的增加以及国际贸易活动的增加等因素预计将在预测期内推动全球医药物流市场的成长。此外，对温度敏感的药品需求的增长以及用于药品物流的RFID技术预计很快就会为药品物流行业创造机会。

市场动态：克制

药品物流和储存缺乏标准化是预测期内阻碍市场成长的因素之一。药品物流和仓储需求受到多种因素的影响，但缺乏标准和认证对市场带来了挑战。这导致人们对仓库空间品质和灵活性的担忧，并增加了製造商适应行业要求的压力。

在温度合规性或容纳自动化设备方面升级设施并不简单。在技术和产品处理方面培训和培养员工需要大量的财务支出。因此，医药物流标准化的缺乏预计将限制医药物流市场的成长。

Overview

Pharmaceutical logistics deals with manufacturing, processing, shipping materials, and resources. It even deals with activities related to the handling of manufactured goods to their customers. For any Pharmaceutical company, the logistics companies play a very crucial role in its functioning. The reason is that they have the responsibility to deliver equipment and drugs on time as at times there are critical and emergencies where the patient needs it urgently. In such a situation every second counts.

Pharmaceutical logistics is one of the most important stages of the operations for any pharmaceutical business as the activities are highly time-sensitive. It is very critical to provide the right medicine to the right patient at the right time, place and dosage and most importantly at the right price.

Market Dynamics: Drivers and Restraints

Rise in advancements in cold chain logistics

Advancements in cold chain logistics are one of the significant factors that help the market to drive during the forecast period. Cold chain logistics ensures that pharmaceutical products are stored and transported at specific temperature ranges to maintain their efficacy and safety. Advancements in temperature monitoring and control technology help prevent temperature excursions, reducing the risk of product spoilage.

For instance, in February 2021, leading supply chain visibility provider Sensitech expanded its suite of IoT devices to include air-carrier-approved and non-lithium battery models for real-time tracking of shipments when cargo is traveling by plane.

The enhanced family of TempTale GEO and VizComm View products support shipments including vaccines, pharmaceuticals and test kits with validated data, enabling critical accept/reject decision-making, regardless of how cargo is moving - by air, land or sea. Sensitech is a part of Carrier Global Corporation, the leading global provider of healthy, safe and sustainable building and cold chain solutions.

Furthermore, factors such as growth in the pharmaceutical sector, increase in demand for reverse logistics in the pharmaceutical sector and increase in international trade activities are anticipated to boost the growth of the global pharmaceutical logistics market during the forecast period. Moreover, the rise in demand for temperature-sensitive pharmaceutical drugs, and RFID technologies for pharmaceutical logistics is expected to create an opportunity for the pharmaceutical logistics industry shortly.

Market Dynamics: Restraint

Lack of standardization in pharmaceutical logistics and storage is one of the factors that hamper the market growth during the forecast period. Pharmaceutical logistics and storage demand is influenced by various sources, but the absence of standards and accreditations poses challenges to the market. This leads to concerns about warehouse space quality and flexibility, and increased pressure on manufacturers to adapt to industry requirements.

It is not straightforward to upgrade the facility in terms of temperature compliance or accommodating automated equipment. Training and growing employees in technology and product handling require significant financial expenditure. As a result, the lack of standardization in pharmaceutical logistics is expected to restrict pharmaceutical logistics market growth.

Segment Analysis

The global pharmaceutical logistics market is segmented based on service type, mode of transport, pharmaceutical product type and region.

The cold chain logistics segment from the service type segment accounted for approximately 41.7% Pharmaceutical Logistics market share

The cold chain logistics segment from the service type segment accounted for approximately 41.7% and it is expected to be dominated during the forecast period. Cold chain logistics is the technology and process that allows for the safe transport of temperature-sensitive goods and products along the supply chain. It relies heavily on science to evaluate and accommodate the link between temperature and perishability. Any product is known to be labelled "perishable" will likely need cold chain management.

For instance, in March 2022, Lineage Logistics LLC, the world's largest and most innovative temperature-controlled industrial REIT and logistics solutions, acquired MTC Logistics, a leading cold-chain provider in four strategic locations on or near the ports of Baltimore, MD, Wilmington, DE, and Mobile, AL. These facilities will expand Lineage's current footprint, which already includes over 400 strategically positioned facilities with a combined capacity of over 2 billion cubic feet across 19 nations.

Moreover, in December 2020, A.P. Moller - Maersk has signed a three-year logistics agreement with Novo Nordisk, covering ocean services and inland logistics. The agreement aims to reduce the pharmaceutical company's carbon footprint in transportation by using sustainable biofuel to power selected Maersk vessels. The agreement demonstrates A.P. Moller-Maersk's rapid transformation into a modern end-to-end logistics company. The partnership also aligns with Novo Nordisk's ambitious sustainability goals, as it demonstrates the company's commitment to sustainability.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the increasing sales of generic drugs, as well as reforms in the healthcare sector favoring generics, several regional and international companies, collaborations with the key players and others help this region to have the highest market share during the forecast period.

For instance, in April 2023, MD Logistics, LLC, a group company of Japan-based Nippon Express Holdings, has opened Garner 2000 Pharmaceutical Logistics Centre, a dedicated pharmaceutical warehouse established in Garner, North Carolina in January this year.

North Carolina is a key hub for the pharmaceutical industry in the United States (US), with numerous major pharmaceutical manufacturers and life science companies having expanded into the state. It is also home to many research institutes and universities that have amassed significant medical knowledge and technologies.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the pharmaceutical logistics market where the COVID-19 pandemic has necessitated the need for temperature-sensitive storage facilities for vaccinations. Also, there was an high demand for temperature-sensitive proteins and nutritional supplements due to evolving consumer lifestyles and dietary habits.

Market Segmentation

Service Type

Cold Chain Logistics
Non-Cold Chain Logistics

Mode of Transport

Air
Water
Road
Rail

Pharmaceutical Product Type

Pharmaceutical Chemicals
Bio-Pharmaceuticals
Pharmaceutical end products
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

major global players in the market include: AIT Worldwide Logistics, Inc., Yusen Logistics, Air Canada Cargo, CEVA Logistics SA, Continental Carriers Pvt Ltd, Deutsche Post AG, FedEx Corporation, Kerry Logistics Network Limited, AWL, Nippon Express Holdings and among others.

Key Developments

In November 2022, UPS acquired healthcare logistics provider Bomi Group to expand its temperature-controlled facilities. With this acquisition, the UPS Healthcare network in Europe and Latin America will gain access to temperature-controlled facilities in 14 countries and over 3,000 highly qualified Bomi Group team members.
In November 2020, Pharma Logistics and ConsortiEX, market leaders in serving the needs of pharmacies and hospitals, launched their new program which is focused on improving inventory efficiency strategic collaboration programs, reducing cost, improving patient safety, and managing cash flow and compliance for their customers.

Why Purchase the Report?

To visualize the global pharmaceutical logistics market segmentation based on service type, mode of transport, pharmaceutical product type and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of pharmaceutical logistics market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global pharmaceutical logistics market report would provide approximately 61 tables, 58 figures and 187 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Service Type
3.2. Snippet by Mode of Transport
3.3. Snippet by Pharmaceutical Product Type
3.4. Snippet by Region

4. Market Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the technological advancements
  - 4.1.1.2. Increase in demand for reverse logistics in the pharmaceutical sector
- 4.1.2. Restraints
  - 4.1.2.1. Lack of standardization in pharmaceutical logistics and storage
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Service Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
- 7.1.2. Market Attractiveness Index, By Service Type
7.2. Cold Chain Logistics *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Non-Cold Chain Logistics

8. By Mode of Transport

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
- 8.1.2. Market Attractiveness Index, By Mode of Transport
8.2. Air*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Water
8.4. Road
8.5. Rail

9. By Pharmaceutical Product Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
- 9.1.2. Market Attractiveness Index, By Pharmaceutical Product Type
9.2. Pharmaceutical Chemicals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Bio-Pharmaceuticals
9.4. Pharmaceutical end products
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.5.1. China
  - 10.5.5.2. India
  - 10.5.5.3. Japan
  - 10.5.5.4. Australia
  - 10.5.5.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Transport
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pharmaceutical Product Type

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. AIT Worldwide Logistics, Inc *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Yusen Logistics
12.3. Air Canada Cargo
12.4. CEVA Logistics SA
12.5. Continental Carriers Pvt Ltd
12.6. Deutsche Post AG
12.7. FedEx Corporation
12.8. Kerry Logistics Network Limited
12.9. AWL
12.10. Nippon Express Holdings

LIST NOT EXHAUSTIVE